Susquehanna International Group
SVA

Susquehanna International Group’s Sinovac Biotech, Ltd SVA Stock Holding History

Susquehanna International Group’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-12,500
Closed -$87K – 10653
2018
Q4 		$87K Sell
12,500
-24,100
-66% -$176K ﹤0.01% 8282
2018
Q3 		$281K Sell
36,600
-13,900
-28% -$100K ﹤0.01% 7608
2018
Q2 		$377K Buy
+50,500
New +$397K ﹤0.01% 7392
2014
Q4 		– Sell
-12,000
Closed -$58K – 10710
2014
Q3 		$58K Sell
12,000
-81,200
-87% -$436K ﹤0.01% 9197
2014
Q2 		$526K Buy
93,200
+64,100
+220% +$389K ﹤0.01% 7377
2014
Q1 		$210K Buy
29,100
+18,500
+175% +$122K ﹤0.01% 8162
2013
Q4 		$65K Sell
10,600
-1,700
-14% -$10.2K ﹤0.01% 8747
2013
Q3 		$74K Buy
+12,300
New +$58.8K ﹤0.01% 8171

Other funds holding SVA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HI
Horizon Investments Charlotte, North Carolina $8.92B AUM 25.62% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Susquehanna International Group's SVA Position: Q1 2026 in Review

Susquehanna International Group held its Sinovac Biotech, Ltd (SVA) position steady in Q1 2026 at 16,430 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #12304.

Susquehanna International Group first reported a position in SVA in Q4 2013 and has held it in 37 quarters since. The position peaked at $402K in Q1 2018. 28 funds tracked by Wall St. Rank hold SVA as of Q1 2026.

  • Susquehanna International Group held 16,430 shares of Sinovac Biotech, Ltd worth $106K as of Q1 2026.
  • Susquehanna International Group left its Sinovac Biotech, Ltd share count unchanged in Q1 2026.
  • Sinovac Biotech, Ltd made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12304 holding.
  • Susquehanna International Group first reported a position in Sinovac Biotech, Ltd in Q4 2013 and has held it in 37 quarters since.
  • Susquehanna International Group's Sinovac Biotech, Ltd position peaked at $402K in Q1 2018.
  • 28 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.